Holen Sie sich die Stockscreener-App
676.14
2.87%
-20.94
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$697.08
Offen:
$703.03
24-Stunden-Volumen:
406.32K
Relative Volume:
0.45
Marktkapitalisierung:
$87.36B
Einnahmen:
$344.58B
Nettoeinkommen (Verlust:
$2.83B
KGV:
30.96
EPS:
21.84
Netto-Cashflow:
$1.63B
1W Leistung:
-2.43%
1M Leistung:
+2.41%
6M Leistung:
+33.20%
1J Leistung:
+29.01%
1-Tages-Spanne:
$675.38
$703.03
1-Wochen-Bereich:
$676.20
$703.03
52-Wochen-Spanne:
$464.42
$728.32
Mckesson Corporation Stock (MCK) Company Profile
Firmenname
Mckesson Corporation
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Vergleichen Sie MCK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
676.07 | 87.36B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
278.16 | 55.07B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
129.66 | 32.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
62.52 | 8.04B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
6.30 | 534.60M | 10.42B | -38.77M | 323.54M | -0.51 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corporation Aktie (MCK) Neueste Nachrichten
McKesson Corporation (MCK): One of the Dividend Stocks with Sustainable Payout Ratios - Yahoo Finance
Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey
McKesson Careers | The future of health starts with you. - McKesson Careers
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant
McKesson is medicine for Elite Investors in market chaos - Citywire
Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey
Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com
McKesson provides Elite Investors with medicine for market choas - Citywire
McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine
McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance
Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Yahoo Finance
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo Finance
3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com
Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey
GS1 US to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
GS1 to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
McKesson (MCK) Sees Price Target Boost to $755 by BofA | CAH Sto - GuruFocus
McKesson To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
McKesson and Wegmans: A Long-Standing Partnership in Advancing Pharmacy - NEWS CHANNEL NEBRASKA
Why the Market Dipped But McKesson (MCK) Gained Today - Yahoo Finance
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance
Jonathan Jackson from Illinois’s 1st district makes notable trades in Microsoft, Salesforce, and McKesson - Investing.com India
This Medical Supplies Distributor Dodges A Tariff Bullet - Investor's Business Daily
Evercore ISI Adjusts Price Target on McKesson to $740 From $675, Maintains Outperform Rating - MarketScreener
McKesson (MCK) Stock Moves -1.38%: What You Should Know - Yahoo Finance
McKesson opens registration for 2025 ideaShare conference - Drug Store News
Registration Opens for Annual McKesson ideaShare Conference - Yahoo Finance
Quad-C Management Completes the Sale of PRISM Vision to McKesson - PR Newswire
Quad-C sells stake in Prism Vision to McKesson Corporation - pehub.com
McKesson Corporation (MCK): Jim Cramer’s Top Pick – Why He Thinks McKesson Can ‘Jack Prices Up’ - Insider Monkey
Zacks Research Brokers Lift Earnings Estimates for McKesson - Defense World
Rite Aid weighs repeat bankruptcy filing, WSJ reports - MarketScreener
McKesson In Huge Group New To IBD 50: Check Out Which Stocks Just Came On – And Off – IBD's Top Stock Screens - Investor's Business Daily
McKesson stock soars to all-time high of $726.13 By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $726.13 - Investing.com
Mizuho raises McKesson stock target to $690, maintains neutral By Investing.com - Investing.com South Africa
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business - TradingView
McKesson Corporation completed the acquisition of 80% stake in PRISM Vision Group from Quad-C Management, Inc. - MarketScreener
Deutsche Bank Adjusts Price Target on McKesson to $692 From $700, Maintains Buy Rating - MarketScreener
Mizuho Adjusts Price Target on McKesson to $690 From $630, Maintains Neutral Rating - MarketScreener
McKesson price target raised to $690 from $630 at Mizuho - TipRanks
Mizuho raises McKesson stock target to $690, maintains neutral - Investing.com India
McKesson Shares Up Over 2% After Key Signal - Benzinga
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns. - Barron's
McKesson (MCK) Poised for Growth in Pharmaceutical Distribution - GuruFocus
Whistleblower Asks Justices to Revive Suit Against McKesson Unit - Bloomberg Law News
McKesson: Morgan Stanley's Top Choice For Pharmaceutical Gains - Finimize
McKesson Likely to See Strong Growth Amid Favorable Pharma Sector, Morgan Stanley Says - MarketScreener
Finanzdaten der Mckesson Corporation-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):